✦ LIBER ✦

Idebenone as a novel, therapeutic approach for Duchenne muscular dystrophy: Results from a 12 month, double-blind, randomized placebo-controlled trial

✍ Scribed by Gunnar M. Buyse; Nathalie Goemans; Marleen van den Hauwe; Daisy Thijs; Imelda J.M. de Groot; Ulrike Schara; Berten Ceulemans; Thomas Meier; Luc Mertens

Book ID: 116794766
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 223 KB
Volume: 21
Category: Article
ISSN: 0960-8966
DOI: 10.1016/j.nmd.2011.02.016

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

T.O.3 SNT-MC17/idebenone in Duchenne mus

T.O.3 SNT-MC17/idebenone in Duchenne muscular dystrophy: long-term blinded controlled preclinical study in the mdx mouse followed by a 12 month double-blind randomized controlled trial in humans

✍ G.M. Buyse; N. Goemans; G. Van der Mieren; M. Erb; J. D’hooge; P. Herijgers; E. 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 50 KB

Efficacy and safety of duloxetine for tr

Efficacy and safety of duloxetine for treatment of fibromyalgia in patients with or without major depressive disorder: Results from a 6-month, randomized, double-blind, placebo-controlled, fixed-dose trial

✍ I. Jon Russell; Philip J. Mease; Timothy R. Smith; Daniel K. Kajdasz; Madelaine 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 608 KB